ARTICLE | Clinical News
Enzon, Santaris preclinical data
December 6, 2010 8:00 AM UTC
In mouse xenograft models of colon and lung cancer, EZN-3892 significantly inhibited tumor growth by 71% and 76%, respectively, vs. saline-treated controls. The beta-catenin (CTNNB1) RNA antagonist w...